---
title: "HEALTHLYNKED CORP | 10-Q: FY2024 Q3 Revenue: USD 590.12 K"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256842177.md"
published_at: "2025-09-11T03:52:13.000Z"
---

# HEALTHLYNKED CORP | 10-Q: FY2024 Q3 Revenue: USD 590.12 K

Revenue: As of FY2024 Q3, the actual value is USD 590.12 K.

EPS: As of FY2024 Q3, the actual value is USD -0.01.

EBIT: As of FY2024 Q3, the actual value is USD -1.973 M.

### Health Services Division

-   **Revenue**: Patient service revenue was $2,249,579 for the nine months ended September 30, 2024, a decrease of 51% from $4,602,081 in the same period in 2023.
-   **Operating Expenses**: Practice salaries and benefits were $1,546,806, a decrease of 41% from $2,635,065 in the same period in 2023. Other practice operating expenses were $1,221,272, a decrease of 32% from $1,799,530 in the same period in 2023.
-   **Impairment Loss**: An impairment charge of $716,000 was recorded for the NCFM Medical Database in the nine months ended September 30, 2024.

### Digital Healthcare Division

-   **Revenue**: Subscription revenue was $48,161 for the nine months ended September 30, 2024, a decrease of 11% from $54,050 in the same period in 2023.
-   **Operating Expenses**: Selling, general, and administrative expenses were $2,444,386, a slight decrease from $2,621,951 in the same period in 2023.

### Medical Distribution Division

-   **Revenue**: Product revenue was $91,694 for the nine months ended September 30, 2024, a decrease of 32% from $135,034 in the same period in 2023.
-   **Operating Expenses**: Cost of product revenue was $86,976, a decrease of 19% from $107,277 in the same period in 2023.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities was $2,750,520 for the nine months ended September 30, 2024, compared to $2,952,574 in the same period in 2023.
-   **Financing Activities**: Net cash provided by financing activities was $2,520,854, primarily from the issuance of notes payable and sale of common stock.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to profitably operate its Health Services business and continue investing in its Digital Healthcare business, including the HealthLynked Network.
-   **Non-Core Business**: The company completed the sale of its ACO/MSO Division on January 17, 2023, and may receive future proceeds from the sale if certain conditions are met.

### Related Stocks

- [HLYKD.US - HEALTHLYNKED CORP](https://longbridge.com/en/quote/HLYKD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| HPC Holdings Ltd. Publishes 2024/2025 Annual Report | HPC Holdings Ltd. has published its Annual Report for the financial year ending 31 October 2025, detailing its activitie | [Link](https://longbridge.com/en/news/275602982.md) |
| Heijmans FY Underlying EBITDA EUR 252 Mln | Koninklijke Heijmans NV :FY REVENUE INCREASES TO EUR 2.8 BILLION (2024: € 2.6 BILLION).FY UNDERLYING EBITDA OF € 252 MIL | [Link](https://longbridge.com/en/news/275857461.md) |
| Mandatum Expects 2026 Fee Result To Increase From 2025 | Mandatum Oyj :MANDATUM FY ASSETS UNDER MANAGEMENT EUR 15,323 MILLIONMANDATUM FY EPS EUR 0.31MANDATUM FY PRETAX PROFIT EU | [Link](https://longbridge.com/en/news/275709943.md) |
| Mercedes-Benz: Will propose dividend of 3.50 EUR per share (2024: 4.30 EUR) | Mercedes-Benz: Will propose dividend of 3.50 EUR per share (2024: 4.30 EUR) | [Link](https://longbridge.com/en/news/275707226.md) |
| SOLV Energy is a bet on solar power. It soared on IPO day. | It is the second-largest solar construction firm, based on its 2024 revenue, according to Engineering News Record. | [Link](https://longbridge.com/en/news/275672105.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.